Hai-Yan Deng Selected Research

Cardiomyopathies (Cardiomyopathy)

4/2011

Thrombopoietin protects against doxorubicin-induced cardiomyopathy, improves cardiac function, and reversely alters specific signalling networks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hai-Yan Deng Research Topics

Disease

2	Gestational Diabetes (Gestational Diabetes Mellitus) 11/2021 - 10/2021
2	Myocardial Infarction 10/2013 - 01/2013
1	Infections 02/2021
1	Ulcer 02/2021
1	Diabetic Foot 02/2021
1	Cough 09/2016
1	Chronic Cough 09/2016
1	Gastroesophageal Reflux (GERD) 09/2016
1	Fibrosis (Cirrhosis) 01/2013
1	Cardiomyopathies (Cardiomyopathy) 04/2011

Drug/Important Bio-Agent (IBA)

1	HomocysteineIBA 11/2021
1	Nicotinamide PhosphoribosyltransferaseIBA 10/2021
1	AlginatesIBA 02/2021
1	Human Growth Hormone (Saizen)FDA LinkGeneric 02/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2016
1	leonurineIBA 01/2013
1	Angiotensin IIIBA 01/2013
1	Thrombopoietin (c-mpl Ligand)IBA 04/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2011

Therapy/Procedure

1	Surgical Amputation (Amputations) 02/2021
1	Therapeutics 09/2016
1	Ligation 10/2013